Jubilant Biosys Limited
Jatin Meher has a broad range of work experience in various companies and roles. Jatin is currently working as an Associate Director - Project Management at Jubilant Biosys Limited, where they lead bioPharma project management, provides strategic direction, and ensures effective project execution across multiple geographies. Prior to that, they worked at Wipro as a Principal Consultant, at GSK as a Project Manager - SPO (Strategy, Portfolio and Operations), and at Pfizer as a Deputy Manager - PMO. Jatin also has experience working at Praj Industries as a Senior Manager, at Panacea Biotec as a Scientific Officer, and at Innodata Inc. as an Associate.
Jatin Meher holds a Master of Business Administration (M.B.A.) degree in Business Administration, Management, and Operations from Birla Institute of Technology and Science, Pilani, which they obtained from 2015 to 2017. Jatin also has a Master of Science (MS) degree in Biotechnology from Utkal University, completed from 2004 to 2006. Additionally, Jatin has obtained certifications in Project Management Professional (PMP), Certified ScrumMaster (CSM), and Financial Modelling and Analysis. The details regarding the specific dates for the certifications are not provided.
This person is not in the org chart
This person is not in any offices
Jubilant Biosys Limited
1 followers
Jubilant Biosys Ltd (JBL) offers end-to-end CRDMO solutions in Structural Biology, Computational Chemistry, Medicinal & Synthetic Chemistry, in-vitro and in-vivo Biology, DMPK, Toxicology, Process R&D & Manufacturing to various Biotech & Pharma companies pursuing drug discovery, development and manufacturing. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Pharmova, serving the global life sciences, agrochemicals and specialty chemicals industry through its research centers & manufacturing facilities in India. Jubilant’s services in discovery research include; Jubilant’s services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain and Inflammation. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.